Cas 903556-96-7,tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate

903556-96-7

Post Buying Request

Basic information

Product Name: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate
Synonyms: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate
CAS NO:903556-96-7
Molecular Formula:
Molecular Weight: 396.486
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate(CAS DataBase Reference)
NIST Chemistry Reference: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate(903556-96-7)
EPA Substance Registry System: tert-butyl (2-benzyloxycarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)methylcarbamate(903556-96-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 903556-96-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

903556-96-7 Suppliers

Recommended suppliers

903556-96-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 903556-96-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,3,5,5 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 903556-96:
(8*9)+(7*0)+(6*3)+(5*5)+(4*5)+(3*6)+(2*9)+(1*6)=177
177 % 10 = 7
So 903556-96-7 is a valid CAS Registry Number.

903556-96-7Upstream product

903556-96-7Downstream Products

903556-96-7Relevant academic research and scientific papers

HETEROBICYCLIC METALLOPROTEASE INHIBITORS

-

Page/Page column 179- 180, (2008/12/05)

The present invention relates generally to heterobicyclic containing pharmaceutical agents, and in particular, to heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic metalloprotease inhibiting compounds that exhibit an increased potency in relation to currently known metalloprotease inhibitors.

HETEROTRICYCLIC METALLOPROTEASE INHIBITORS

-

Page/Page column 70-71, (2008/12/05)

The present invention relates generally to azatricyclic containing pharmaceutical agents, and in particular, to azatricyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azatricyclic MMP-3, MMP-8 a

Substituted bis-amide metalloprotease inhibitors

-

Page/Page column 33-34, (2010/11/27)

This invention relates to substituted bis-amide pyrimidine compounds of Formula (I), which are useful for the treatment of metalloprotease mediated diseases, in particular MMP-13 related diseases.

Multicyclic bis-amide MMP inhibitors

-

Page/Page column 102, (2008/06/13)

The present invention relates generally to bis-amide group containing pharmaceutical agents, and in particular, to multicyclic bis-amide MMP-13 inhibitor compounds. More particularly, the present invention provides a new class of MMP-13 inhibiting compounds, containing a pyrimidinyl bis-amide group in combination with a heterocyclic moiety, that exhibit an increased potency and solubility in relation to currently known bis-amide group containing MMP-13 inhibitors.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 903556-96-7